Profile data is unavailable for this security.
About the company
Tristel plc is a United Kingdom-based manufacturer of infection prevention products. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. The Company is also focused on pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.
- Revenue in GBP (TTM)41.93m
- Net income in GBP6.49m
- Incorporated2003
- Employees213.00
- LocationTristel PLCLynx Business Park,Fordham RoadSNAILWELL CB8 7NYUnited KingdomGBR
- Phone+44 163 872 1500
- Fax+44 163 872 1911
- Websitehttps://tristel.com/hk-en/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inspecs Group PLC | 195.14m | -4.11m | 51.34m | 1.67k | -- | 0.5037 | 6.03 | 0.2631 | -0.0404 | -0.0404 | 1.92 | 1.00 | 0.8667 | 2.31 | 7.65 | 116,640.80 | -1.82 | -1.48 | -2.62 | -2.15 | 51.46 | 48.50 | -2.10 | -1.97 | 0.8696 | 0.6441 | 0.377 | -- | 1.16 | 36.45 | 84.22 | -- | 51.04 | -- |
| SDI Group PLC | 65.85m | 4.23m | 61.69m | 503.00 | 14.68 | 1.36 | 7.49 | 0.9368 | 0.0402 | 0.0402 | 0.6256 | 0.4344 | 0.793 | 0.989 | 5.34 | 130,906.60 | 5.12 | 7.85 | 6.11 | 10.01 | 30.84 | 64.06 | 6.46 | 9.48 | 1.35 | 4.85 | 0.321 | 0.00 | -2.56 | 30.46 | 9.30 | 17.22 | 12.08 | -- |
| Creo Medical Group PLC | 30.30m | -22.40m | 68.52m | 278.00 | -- | 1.27 | -- | 2.26 | -0.0629 | -0.0629 | 0.0852 | 0.1311 | 0.3835 | 1.85 | 3.33 | 105,574.90 | -28.35 | -26.07 | -32.89 | -30.94 | 49.50 | 47.58 | -73.93 | -118.24 | 2.38 | -- | 0.2305 | -- | 13.36 | -- | 19.44 | -- | -- | -- |
| EKF Diagnostics Holdings PLC | 50.95m | 4.78m | 116.61m | 309.00 | 24.43 | 1.69 | 11.67 | 2.29 | 0.0105 | 0.0105 | 0.1123 | 0.1516 | 0.6307 | 3.01 | 6.99 | 160,728.70 | 6.34 | 5.20 | 7.35 | 6.13 | 48.05 | 50.04 | 10.05 | 7.91 | 3.08 | 1,703.50 | 0.0175 | 113.68 | -21.05 | 4.34 | 123.28 | -25.30 | 30.37 | -- |
| Aoti Inc | 39.43m | -7.48m | 137.81m | 80.00 | -- | 11.26 | -- | 3.49 | -0.0703 | -0.0703 | 0.3707 | 0.115 | 1.56 | 3.57 | 8.18 | 328,593.30 | -29.55 | -- | -41.81 | -- | 85.76 | -- | -18.96 | -- | 2.57 | -3.08 | 0.4812 | -- | 31.06 | -- | -191.92 | -- | -- | -- |
| Tristel Plc | 41.93m | 6.49m | 209.77m | 213.00 | 32.60 | 6.45 | 22.81 | 5.00 | 0.135 | 0.135 | 0.8714 | 0.6818 | 0.9812 | 1.81 | 5.74 | -- | 15.18 | 9.32 | 17.75 | 10.76 | 80.08 | 80.75 | 15.47 | 11.09 | 3.04 | -- | 0.1532 | 109.35 | 16.45 | 9.89 | 45.46 | 9.99 | 10.13 | 19.53 |
| Advanced Medical Solutions Group plc | 131.11m | 11.13m | 456.26m | 1.50k | 41.07 | 1.88 | 20.31 | 3.48 | 0.051 | 0.051 | 0.6011 | 1.12 | 0.3977 | 1.70 | 4.91 | 154,244.70 | 3.38 | 6.54 | 3.64 | 7.06 | 54.45 | 56.75 | 8.49 | 14.82 | 6.80 | -- | 0.2702 | 25.85 | 1.51 | 4.23 | -22.14 | -6.71 | 15.66 | 12.32 |
| Holder | Shares | % Held |
|---|---|---|
| Liontrust Investment Partners LLPas of 10 Jun 2024 | 5.05m | 10.59% |
| Charles Stanley & Co. Ltd. (Investment Management)as of 30 Jun 2023 | 4.74m | 9.95% |
| Rathbones Investment Management Ltd.as of 21 Sep 2023 | 3.35m | 7.03% |
| Aviva Investors Global Services Ltd.as of 30 Jun 2024 | 3.12m | 6.55% |
| Schroder Investment Management Ltd.as of 02 Sep 2024 | 3.10m | 6.51% |
| Montanaro Asset Management Ltd.as of 30 Jun 2023 | 3.00m | 6.29% |
| Investec Wealth & Investment Ltd.as of 30 Jun 2023 | 2.19m | 4.59% |
| Interactive Investor Services Ltd.as of 30 Jun 2023 | 2.04m | 4.27% |
| Unicorn Asset Management Ltd.as of 30 Jun 2023 | 1.94m | 4.06% |
| BGF Investment Management Ltd.as of 27 Jul 2023 | 1.93m | 4.05% |
